NCT03216928View on ClinicalTrials.gov

A New Mode of Action of Anti-TNF, Reverse Signaling, in Rheumatoid Arthritis

NACompletedINTERVENTIONAL
Enrollment

33

Participants

Timeline

Start Date

January 31, 2017

Primary Completion Date

March 12, 2020

Study Completion Date

March 12, 2020

Conditions
Rheumatoid Arthritis
Interventions
DIAGNOSTIC_TEST

Blood test

Trial Locations (1)

31059

University Hospital Toulouse, Toulouse

All Listed Sponsors
lead

University Hospital, Toulouse

OTHER

NCT03216928 - A New Mode of Action of Anti-TNF, Reverse Signaling, in Rheumatoid Arthritis | Biotech Hunter | Biotech Hunter